Sign In
Buy PEN
$319.37
+0.630 (+0.198%)
At Close: Jun 03, 2026
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Penumbra, Inc. (NYSE:PEN) resu
Penumbra, Inc. to Present at the 2021 Wells Fargo Virtual Healthcare Conference
04:05pm, Thursday, 26'th Aug 2021
ALAMEDA, Calif., Aug. 26, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 2021 Wells Fargo Virtual Healthcare Conference on Thu
Penumbra Q2 Earnings Beat Estimates; Raises FY21 Sales Outlook
05:28pm, Tuesday, 10'th Aug 2021
Penumbra Inc (NYSE: PEN) reported Q2 sales of $184.3 million, an increase of 75.3% Y/Y, or 72.7% on a constant currency basis, beating the consensus of $170.76 million. Revenue from sales of vascula
Penumbra, Inc.'s (PEN) CEO Adam Elsesser on Q2 2021 Results - Earnings Call Transcript
09:11pm, Monday, 09'th Aug 2021
Penumbra, Inc.'s (PEN) CEO Adam Elsesser on Q2 2021 Results - Earnings Call Transcript
Penumbra, Inc. Reports Second Quarter 2021 Financial Results
04:05pm, Monday, 09'th Aug 2021
ALAMEDA, Calif., Aug. 9, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the second quarter ended J
Penumbra, Inc. to Present at the Canaccord Genuity 41st Annual Growth Conference
04:05pm, Wednesday, 28'th Jul 2021
ALAMEDA, Calif., July 28, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity 41st Annual Growth Conference on Wed
Penumbra: Short Thesis Did Not Hold, Core Business Remains Strong
03:27am, Saturday, 24'th Jul 2021
Penumbra: Short Thesis Did Not Hold, Core Business Remains Strong
Penumbra, Inc. Schedules Second Quarter 2021 Earnings Release and Conference Call for August 9, 2021
04:05pm, Monday, 12'th Jul 2021
ALAMEDA, Calif., July 12, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2021 after market clo
Penumbra (PEN) Gets FDA Nod for RED 62, Grows Thrombectomy Line
12:47pm, Friday, 25'th Jun 2021
Penumbra (PEN) to initiate commercialization of RED 62 Reperfusion Catheter post FDA clearance.
Penumbra, Inc. to Present at the William Blair 41st Annual Growth Stock Virtual Conference
04:05pm, Tuesday, 18'th May 2021
ALAMEDA, Calif., May 18, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the William Blair 41st Annual Growth Stock Virtual Conferen
Penumbra (PEN) Q1 Earnings and Revenues Surpass Estimates
09:02pm, Tuesday, 04'th May 2021
Penumbra (PEN) delivered earnings and revenue surprises of 145.45% and 10.41%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Penumbra, Inc. (PEN) CEO Adam Elsesser on Q1 2021 Results - Earnings Call Transcript
07:22pm, Tuesday, 04'th May 2021
Penumbra, Inc. (PEN) CEO Adam Elsesser on Q1 2021 Results - Earnings Call Transcript
Penumbra: Q1 Earnings Insights
04:54pm, Tuesday, 04'th May 2021
Shares of Penumbra (NYSE:PEN) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 0.00% over the past year to $0.27, which beat the e
This Medical Device Company Just Got a Big Boost
06:12am, Friday, 30'th Apr 2021
If you like good news and support from experts, this one's for you.
Penumbra, Inc. to Present at the BofA Securities 2021 Virtual Health Care Conference
04:05pm, Tuesday, 27'th Apr 2021
ALAMEDA, Calif., April 27, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the BofA Securities 2021 Virtual Health Care Conference
